Why Amgen Is Called to Outperform Large-Cap Biotechs
Credit Suisse has set an Outperform rating and $290 price target on Amgen shares. That target implies more than 20% upside to the stock's recent trading price.
Credit Suisse has set an Outperform rating and $290 price target on Amgen shares. That target implies more than 20% upside to the stock's recent trading price.
Why is SPI Energy stock running so much, and what makes it stand out? Here are 10 things to know about the company before investing.
Darden Restaurants released mixed fiscal first-quarter financial results and said it resumed its dividend before the markets opened on Thursday.
Emerging consumer products provider Laird Super Food was another initial public offering making a big splash in the market on Wednesday.
Telemedicine platform provider GoodRx entered the market with a bang on Wednesday.
AC Immune stock was absolutely crushed on Wednesday after the firm announced disappointing results from its midstage Alzheimer’s disease study.
MediciNova has announced progress in its COVID-19 vaccine prototype, which stands out from the rest as it is administered intranasally.
SPI Energy shares more than tripled on Wednesday after the company announced that it would be getting into the electric vehicle business.
Stitch Fix posted a larger than expected net loss for its fiscal fourth-quarter, and shares plunged in early trading Wednesday.
CleanSpark, Inc. (NASDAQ: CLSK) closed Monday on a positive note although the markets slumped. The reason behind this move was that the firm announced the commissioning of its software on a new solar plus…
Roku shares made a solid move higher on Monday after the company announced that it would be adding NBC’s Peacock to its platform.
Illumina shares dipped early Monday after the company announced that it would be making a critical acquisition of Grail.
Microsoft aims to acquire ZeniMax Media and its game publisher, Bethesda Softworks, bringing Elder Scrolls, Doom, Fallout and Wolfenstein under its banner.
Precision oncology company PMV Pharmaceuticals intends to price more than 7.35 million shares for an initial public offering valued up to around $152 million.
24/7 Wall St. has previewed Nike, Rite Aid and some of the other key companies expected to report quarterly results this week.
As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple of weeks, firms working toward this goal have taken steps forward and back, which…
San Francisco-based Unity Software entered the market with a bang on Friday.
Cancer-detection-focused health care company Grail has filed with the SEC, regarding its initial public offering.
Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) has announced that it will push forward with a midstage trial in the treatment of COVID-19.
Sorrento Therapeutics shares jumped on Thursday after the company announced that it received approval from the FDA for its COVID-19 treatment.